Mina T Kelleni

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 18

Top Venues

Inflammopharmacology

Irish journal of medical science

SN comprehensive clinical medicine

Human vaccines & immunotherapeutics

Minia University Faculty of Medicine

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Minia University Faculty of Medicine

Egypt

Assistant Professor :: Pharmacology

Publications

Mina T Kelleni
Repurposing metformin to manage idiopathic or long COVID Tinnitus: self-report adopting a pathophysiological and pharmacological approach. Inflammopharmacology 32 (2) (2024)
Mina T Kelleni
Repurposing metformin to manage idiopathic or long COVID Tinnitus: self-report adopting a pathophysiological and pharmacological approach. Inflammopharmacology 32 (2) (2024)
Mina T Kelleni
Angiotensin receptor blockers could be superior to angiotensin-converting enzyme inhibitors in COVID-19 management: the potential role of bradykinin. Irish journal of medical science 193 (4) (2024)
Mina T Kelleni
Repurposing metformin to manage idiopathic or long COVID Tinnitus: self-report adopting a pathophysiological and pharmacological approach. Inflammopharmacology (2024)
Mina T Kelleni
Angiotensin receptor blockers could be superior to angiotensin-converting enzyme inhibitors in COVID-19 management: the potential role of bradykinin. Irish journal of medical science (2024)
Mina T Kelleni
Repurposing metformin to manage idiopathic or long COVID Tinnitus: self-report adopting a pathophysiological and pharmacological approach. Inflammopharmacology 32 (2) (2024)
Mina T Kelleni
Repurposing metformin to manage idiopathic or long COVID Tinnitus: self-report adopting a pathophysiological and pharmacological approach. Inflammopharmacology 32 (2) (2024)
Mina T Kelleni
Repurposing metformin to manage idiopathic or long COVID Tinnitus: self-report adopting a pathophysiological and pharmacological approach. Inflammopharmacology 32 (2) (2024)
Mina T Kelleni
Repurposing metformin to manage idiopathic or long COVID Tinnitus: self-report adopting a pathophysiological and pharmacological approach. Inflammopharmacology 32 (2) (2024)
Mina T Kelleni
Real-world practice of the Egyptian Kelleni's protocol amid changing tropism of SARS-CoV-2 omicron BA.5.2.1.7, XBB 1.5 and CH.1.1 subvariants: a multi-purpose protocol. Inflammopharmacology (2023)
Mina T Kelleni
Real-world practice of the Egyptian Kelleni's protocol amid changing tropism of SARS-CoV-2 omicron BA.5.2.1.7, XBB 1.5 and CH.1.1 subvariants: a multi-purpose protocol. Inflammopharmacology (2023)
Mina T Kelleni
The African Kelleni's roadmap using nitazoxanide and broad-spectrum antimicrobials to abort returning to COVID-19 square one. Inflammopharmacology (2023)
Mina T Kelleni
COVID-19, Ebola virus disease, and Nipah virus infection reclassification as novel acute immune dysrhythmia syndrome (n-AIDS): potential crucial role for immunomodulators. Immunologic research 69 (5) (2021)
Mina T Kelleni
Tocilizumab, Remdesivir, Favipiravir, and Dexamethasone Repurposed for COVID-19: a Comprehensive Clinical and Pharmacovigilant Reassessment. SN comprehensive clinical medicine (2021)
Mina T Kelleni
NSAIDs/nitazoxanide/azithromycin repurposed for COVID-19: potential mitigation of the cytokine storm interleukin-6 amplifier via immunomodulatory effects. Expert review of anti-infective therapy (2021)
Mina T Kelleni
BCG vaccination potential for COVID-19: an analytical approach. Human vaccines & immunotherapeutics 17 (8) (2021)
Mina T Kelleni
NSAIDs and Kelleni's protocol as potential early COVID-19 treatment game changer: could it be the final countdown? Inflammopharmacology (2021)
Mina T Kelleni
ACEIs, ARBs, ibuprofen originally linked to COVID-19: the other side of the mirror. Inflammopharmacology 28 (6) (2020)

Mina T Kelleni.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Mina T Kelleni